Basic Information
| LncRNA/CircRNA Name | LINC00339 |
| Synonyms | NA |
| Region | NA |
| Ensemble | ENSG00000218510 |
| Refseq | NR_023918 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, Luciferase reporter assay, RIP |
| Sample | ovarian cancer tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | LINC00339 was overexpressed in ovarian cancer tissues, showed a poor prognosis in patients with ovarian cancer, and correlated with tumor size and advanced clinical stages. |
| Pubmed ID | 31550677 |
| Year | 2019 |
| Title | LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes. |
External Links
| Links for LINC00339 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |